Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
12.57
+0.05 (0.40%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Zymeworks Employees
As of December 31, 2024, Zymeworks had 286 total employees, including 280 full-time and 6 part-time employees. The number of employees increased by 8 or 2.88% compared to the previous year.
Employees
286
Change (1Y)
8
Growth (1Y)
2.88%
Revenue / Employee
$266,797
Profits / Employee
-$429,003
Market Cap
874.58M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ZYME News
- 1 day ago - Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - GlobeNewsWire
- 6 days ago - Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - GlobeNewsWire
- 10 days ago - Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewsWire
- 4 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting - GlobeNewsWire
- 7 weeks ago - Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251 - Benzinga
- 7 weeks ago - Zymeworks Inc. (ZYME) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire